Top 2010 QC & recall news
Johnson & Johnson (J&J) dominated recall and quality control (QC) news over the past year but others also faced issues. in-PharmaTechnologist presents five of our most read QC articles of 2010.
Archives for December 22, 2010
'Chindia' could become global generic powerhouse
China’s PM Wen Jiabao has vowed to improve market access for Indian pharmaceutical companies to better supply global generic drug needs.
Interactive map of EMA GCP inspections from 2000-09
Outsourcing-Pharma presents an interactive map showing EMA GCP inspections from 2000 to 2009 by type, routine and triggered, and year.
Pfizer recalls more Lipitor after pallet-linked odour detected
Pfizer is to recall a further 19,000 bottles of Lipitor (atorvastatin calcium) from the US after a customer reported “an uncharacteristic odour”.
Top 5 consolidation, cutback & closure articles of 2010
The contract service market failed to recover as hoped in 2010 and consequently many companies made cutbacks. Outsourcing-Pharma rounds up five of the most read of 2010.
Catalent fined after contact with olanzapine leads to dermatitis
Catalent has been fined after contact with olanzapine led to employees developing dermatitis, an incident the company “deeply regrets”.